| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of age and BMI with kidney function and mortality: a cohort study
|
Lu, Jun Ling
|
|
2015
|
3 |
9 |
p. 704-714
11 p.
|
artikel
|
| 2 |
Body language
|
Diekman, Theo
|
|
2015
|
3 |
9 |
p. 746-
1 p.
|
artikel
|
| 3 |
Cardiovascular safety of albiglutide and other glucagon-like peptide-1 receptor agonists
|
Scheen, André J
|
|
2015
|
3 |
9 |
p. 667-669
3 p.
|
artikel
|
| 4 |
Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis
|
Fisher, Miles
|
|
2015
|
3 |
9 |
p. 697-703
7 p.
|
artikel
|
| 5 |
CCR2 inhibition: a panacea for diabetic kidney disease?
|
Weir, Matthew R
|
|
2015
|
3 |
9 |
p. 666-667
2 p.
|
artikel
|
| 6 |
Correction to Lancet Diabetes Endocrinol 2014; 2: 691–700
|
|
|
2015
|
3 |
9 |
p. e7-
1 p.
|
artikel
|
| 7 |
Costs and benefits of iodine supplementation for pregnant women in a mildly to moderately iodine-deficient population: a modelling analysis
|
Monahan, Mark
|
|
2015
|
3 |
9 |
p. 715-722
8 p.
|
artikel
|
| 8 |
Country in Focus: economic transition and non-communicable diseases in Thailand
|
Xanthos, Dimitris
|
|
2015
|
3 |
9 |
p. 684-685
2 p.
|
artikel
|
| 9 |
Diabetic foot disease: moving from roadmap to journey
|
Lipsky, Benjamin A
|
|
2015
|
3 |
9 |
p. 674-675
2 p.
|
artikel
|
| 10 |
Diabetic kidney disease: what does the next era hold?
|
The Lancet Diabetes & Endocrinology,
|
|
2015
|
3 |
9 |
p. 665-
1 p.
|
artikel
|
| 11 |
Endocrinology in focus: photo competition 2015
|
Bennet, Neil
|
|
2015
|
3 |
9 |
p. 677-678
2 p.
|
artikel
|
| 12 |
Glucose management in critically ill adults and children
|
Mesotten, Dieter
|
|
2015
|
3 |
9 |
p. 723-733
11 p.
|
artikel
|
| 13 |
Iodine deficiency in pregnant women in Europe
|
Zimmermann, Michael B
|
|
2015
|
3 |
9 |
p. 672-674
3 p.
|
artikel
|
| 14 |
Iodine deficiency in pregnant women in the UK: the costs of inaction
|
Pearce, Elizabeth N
|
|
2015
|
3 |
9 |
p. 671-672
2 p.
|
artikel
|
| 15 |
Kidneys do not like excess body fat
|
Wanner, Christoph
|
|
2015
|
3 |
9 |
p. 669-671
3 p.
|
artikel
|
| 16 |
Mortality and metformin use in patients with advanced chronic kidney disease
|
Lalau, Jean-Daniel
|
|
2015
|
3 |
9 |
p. 680-681
2 p.
|
artikel
|
| 17 |
Mortality and metformin use in patients with advanced chronic kidney disease – Authors' reply
|
Hung, Szu-Chun
|
|
2015
|
3 |
9 |
p. 681-
1 p.
|
artikel
|
| 18 |
Neoliberalism and global health—a blind alley?
|
Bärnighausen, Till
|
|
2015
|
3 |
9 |
p. 685-686
2 p.
|
artikel
|
| 19 |
Nutritional support in critical illness and recovery
|
Casaer, Michael P
|
|
2015
|
3 |
9 |
p. 734-745
12 p.
|
artikel
|
| 20 |
Research in brief
|
Kang, Seema
|
|
2015
|
3 |
9 |
p. 683-
1 p.
|
artikel
|
| 21 |
Testosterone and cardiovascular risk
|
Schooling, C Mary
|
|
2015
|
3 |
9 |
p. 682-
1 p.
|
artikel
|
| 22 |
The challenge of diabetes in sub-Saharan Africa
|
Atun, Rifat
|
|
2015
|
3 |
9 |
p. 675-677
3 p.
|
artikel
|
| 23 |
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
|
de Zeeuw, Dick
|
|
2015
|
3 |
9 |
p. 687-696
10 p.
|
artikel
|
| 24 |
The revised NICE draft guideline for type 2 diabetes: still a long way to go
|
O'Hare, J Paul
|
|
2015
|
3 |
9 |
p. 679-680
2 p.
|
artikel
|
Tijdschrift beschrijving